Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of acromegaly patients at the time of diagnosis

From: Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients

  SE ± mean (Range)   n (%)
Age (years) 46.2 ± 1.4 (18–75) Number of microadenomas 8/62 (13%)
Age at the time of diagnosis (years) 38.2 ± 1.4 (8–65) Number of macroadenomas 54/62 (87%)
Time to diagnosis (years) 4.5 ± 0.3 (1–14) Hyperprolactinemia 13/62 (21%)
Follow-up duration 7.3 ± 0.8 (1–29) Hypertension 13/62 (21%)
GH level (ng/ml); (n = 54) 39.18 (2.1–179) Diabetes Mellitus 22/62 (35%)
#IGF-1 level (ng/ml); (n = 41) 993.5 ± 79 (262–3000) Carpal Tunnel Syndrome 2/62 (3.2%)
IGF-1 level (n = 1)* 1700 ± 0 Menstrual irregularity 4/32 (12.5%)
IGF-1 levels (n = 4)** 1318 ± 788 Loss of libido 2/62 (3.2%)
IGF-1 levels (n = 17)*** 770.5 ± 694 Galactorrhea 4/62 (6.5%)
IGF-1 levels (n = 19)**** 1078 ± 1249 Headache 4/62 (6.5%)
   Typical facial findings and growth in hands and feet 55/62 (92%)
  1. #IGF-1 levels (based on age and gender).
  2. *Male, for 6–8 years; normal range of IGF-1: 110-565 ng/ml.
  3. **Female and male, for 16–25years; normal range of IGF-1: 182-780 ng/ml.
  4. ***Female, for > 25 years; normal range of IGF-1: 123-463 ng/ml.
  5. ****Male, for > 25 years; normal range of IGF-1: 123-463 ng/ml.